Form 4 for CRL Charles River Laboratories
Accepted 2025-06-04 00:00:00 ET · period of report 2025-06-02 · accession 0001127602-25-016724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-04 | 2025-06-02 | CRL | Barg Steven | Dir | A - Grant | $135.04 | +1,427 | 1,427 | New | +$192.7K |
| D | 2025-06-04 | 2025-06-02 | CRL | Barg Steven | Dir | A - Grant | $135.04 | +2,082 | 2,082 | New | +$281.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-02 | A | A | 481 | $135.04 | 481 | D | — | — | (F1) The grant was made in lieu of director service fees for the term commencing May 20, 2025. The restricted stock units vest upon the earlier of 6/2/2026, or the business day prior to the Company's next annual meeting of shareholders. |
| 2 | Common | Common Stock | 2025-06-02 | A | A | 946 | $135.04 | 1,427 | D | — | — | (F2) The unvested restricted stock units vest upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders. |
| 3 | Derivative | Stock Options (Right to Buy) | 2025-06-02 | A | A | 2,082 | $135.04 | 2,082 | D | $135.04 · 2026-06-02 to 2035-06-02 | 2,082 Common Stock | (F3) The stock options become exercisable upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders. |